IMMUNOGLOBULIN M - ANVISA Registration 10350840032
Access comprehensive regulatory information for IMMUNOGLOBULIN M in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10350840032 and manufactured by APTEC DIAGNOSTICS NV. The registration is held by BIOSYS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, BECKMAN COULTER INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
10350840032
250000377799881
02220795000179
Company Information
Dates and Status
Feb 25, 1999
VIGENTE
09/18/2025 19:00:01
IMMUNOGLOBULIN M
IgM
VYTTRA DIAGNOSTICOS S.A.
81692610211
Dec 10, 2020
IMMUNOGLOBULIN M
IgM
BECKMAN COULTER INC.
10033120679
May 14, 2012
IMMUNOGLOBULIN M
IgM
LABORLAB PRODUTOS PARA LABORATÓRIOS LTDA EPP
10246810168
Dec 08, 2014
IMMUNOGLOBULIN M
IgM
WIENER LABORATÓRIOS S.A.I.C.
10246810168
Dec 08, 2014
IMMUNOGLOBULIN M
IGM
GT LABORATORIOS SRL
80538800011
Jul 20, 2015
IMUNOGLOBULINA M
Imunoglobulina M (IgM)
DIAGAM S.A.
81546350084
Aug 18, 2025
IMUNOGLOBULINA M
FamĂlia Imunoglobulina M (IgM)
KATAL BIOTECNOLOGICA INDÚSTRIA E COMÉRCIO LTDA
10377390322
Jun 09, 2025
IMUNOGLOBULINA M
FamĂlia Imunoglobulina M (IgM)
BIOSYSTEMS S.A.
80367750175
Feb 27, 2023
IMUNOGLOBULINA M
Immunoglobulin M
THERMO FISHER SCIENTIFIC OY
80254180448
Jul 14, 2022
IMUNOGLOBULINA M
FamĂlia HYDRASHIFT 2/4 ISATUXIMAB
SEBIA S.A.
80416660084
May 13, 2021